Psyched Wellness Announces Successful Pilot Run, Final Flavour Profile for Calm and Shipping Pre-Orders in October
Toronto, Ontario- - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, is pleased to announce positive feedback from test subjects who participated in the pilot run of 300 bottles of Calm. This feedback provided the company with the necessary information to determine the final flavour formulation for Calm. Additionally, the Company is pleased to share that pre orders are now sold out and shipping will commence mid to end of October.
Key Takeaways from Pilot Run:
An ideal dose (for maximum effect) will range from 1ml to 2ml depending on the users familiarity with Amanita Muscaria products
The majority of the test subjects experienced desired effects (calming and relaxing sensation) with recommended serving
The majority of the test subjects felt that they woke the next day well-rested and with little to no grogginess
Feedback from test subjects helped identify the final flavour profile
Pilot run helped our CMO identify extraction efficiencies that will enhance production, increasing efficiency and lowering cost of goods
Jeffrey Stevens, CEO of the Company says, “We have taken a cautious approach to bringing our flagship product, Calm, to market. We have been working closely with Vantage Hemp, our contract manufacturer and providing them with the feedback from our test participants to ensure we produce the best version of Calm for our consumers.”
“These are very exciting times!'', says David Shisel, COO of the Company, “Shipping CALM, our Amanita Muscaria product that we are all using for our wellness, to real customers outside of our internal focus groups, marks a very significant milestone in our company’s progression. We are extremely excited for everyone to try it”.